Frontier and emerging markets (Vietnam)

Dylan Waller

Nomadic Equity

Thematic (Sector/Industry)

<p>Investors should not continue to overlook Pakistan's stock market, which stands out for its strong performance and PER discount to other frontier markets in Asia.  A potential emerging market upgrade announcement has the potential to be a catalyst for well deserved increased recognition for this country's stock market.  The MSCI will be reviewing Pakistan's eligibility today.  The index has returned a modest 6.72% in the past year, yet an emerging market upgrade in 2017 has the potential to…</p>

Investors should not continue to overlook Pakistan's stock market, which stands out for its strong performance and PER discount to other frontier markets in Asia.  A potential emerging market upgrade announcement has the potential to be a catalyst for well deserved increased recognition for this country's stock market.  The MSCI will be reviewing Pakistan's eligibility today.  The index has returned a modest 6.72% in the past year, yet an emerging market upgrade in 2017 has the potential to…

Pakistan's Pharmaceutical Industry: Potential FDA Approval/Drug to Rival Gilead

Pakistan

The Searle Co Ltd manufactures and sells pharmaceutical and healthcare products. The Company also sells a range of food products and consumer items.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

The Searle (SEARL PA)

Pakistan's Pharmaceutical Industry: Potential FDA Approval/Drug to Rival Gilead

Investors should not continue to overlook Pakistan's stock market, which stands out for its strong performance and PER discount to other frontier...

Nomadic Equity

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)